American Association of Acupuncture and Oriental Medicine

We serve to advance the profession and practice of AOM

  • 06 Sep 2016 2:11 PM | AAAOM Admin (Administrator)

    05/31/2008 - ACUPUNCTURE REDUCES PAIN AND DYSFUNCTION IN HEAD AND NECK CANCER PATIENTS AFTER NECK DISSECTION

    Posted By Administration, Saturday, May 31, 2008
    Updated: Friday, July 11, 2014

    [Memorial Sloan Kettering Cancer Center] New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection.

    http://www.mskcc.org/pressroom/press/acupuncture-reduces-pain-and-dysfunction-head-and-neck-patients-after-neck-dissection


  • 06 Sep 2016 2:10 PM | AAAOM Admin (Administrator)

    10/02/2008 - CALMING CHILDREN BEFORE SURGERY

    Posted By Administration, Sunday, November 02, 2008
    Updated: Friday, July 11, 2014

    Edit Post  Delete Post 

    [UC Irvine] Surgery is stressful for even the calmest patient, but for children it can be particularly traumatic and frightening. For anesthesiologists, soothing anxious children about to enter surgery is a critical part of the job, and Dr. Zeev Kain, anesthesiology & perioperative care chair at UC Irvine, is turning to ancient Chinese medicine for new methods.

    http://news.uci.edu/features/calming-children-before-surgery/


  • 06 Sep 2016 2:09 PM | AAAOM Admin (Administrator)

    03/31/2009 ACUPUNCTURE AND ORIENTAL MEDICINE (AOM) IN THE UNITED STATES

    Posted By Administration, Tuesday, March 31, 2009
    Updated: Tuesday, July 15, 2014

    [AAAOM/SAR] Written cooperatively by the American Association of Acupuncture and Oriental Medicine (AAAOM) and the Society for Acupuncture Research (SAR), this document presents a general background on the field of acupuncture as it relates to traditional Chinese medicine and, in addition, provides information on the safety and cost-effectiveness of this intervention as well as the education and entry level requirements for the profession. Further, the AAAOM and SAR jointly request that fully trained and licensed professionals in the field of acupuncture and Oriental Medicine (AOM) participate in the dialogues that develop healthcare policies and reform at the national level.

    https://www.aaaomonline.org/page/AOMinUS/?


  • 06 Sep 2016 2:08 PM | AAAOM Admin (Administrator)
    AAAOM_EHB_Economic_Evaluatio.pdf

    09/01/2009 - ECONOMIC EVALUATION IN ACUPUNCTURE: PAST AND FUTURE

    Posted By Administration, Tuesday, September 01, 2009
    Updated: Tuesday, July 15, 2014

    [American Acupuncturist] As health care reform continues to be the nation’s priority, we are pleased to introduce an important article entitled "Economic Evaluation in Acupuncture,” written by Michael Jabbour, LAc, MS. This article profiles a recent study on both the cost effectiveness and cost benefits of acupuncture. This is an in-depth view of the financial value of acupuncture in the current U.S. health care system.


  • 06 Sep 2016 2:07 PM | AAAOM Admin (Administrator)

    02/05/2010 - STUDY MAPS EFFECTS OF ACUPUNCTURE ON THE BRAIN

    Posted By Administration, Friday, February 05, 2010
    Updated: Friday, July 11, 2014

    [Science Daily] New research about the effects of acupuncture on the brain may provide an understanding of the complex mechanisms of acupuncture and could lead to a wider acceptability of the treatment.

    http://www.sciencedaily.com/releases/2010/02/100204101736.htm


  • 06 Sep 2016 2:06 PM | AAAOM Admin (Administrator)

    03/30/2010 - ACUPUNCTURE CALMS HIGHLY ANXIOUS DENTAL PATIENTS, STUDY SUGGESTS

    Posted By Administration, Tuesday, March 30, 2010
    Updated: Friday, July 11, 2014

    [Science Daily] Acupuncture can calm highly anxious dental patients and ensure that they can be given the treatment they need, suggests a small study.

    http://www.sciencedaily.com/releases/2010/03/100329203535.htm


  • 06 Sep 2016 2:05 PM | AAAOM Admin (Administrator)

    05/11/2011 - ACUPUNCTURE FOR CHRONIC LOW BACK PAIN

    Posted By Administration, Wednesday, May 11, 2011
    Updated: Friday, July 11, 2014

    [NCCAM] In a study published in the Archives of Internal Medicine, acupuncture or simulated acupuncture treatments fared better than usual care in managing low back pain. However, neither tailoring acupuncture needle sites to the individual nor penetrating the skin appeared to be essential for receiving therapeutic benefit. These results are of importance to patients and practitioners seeking a relatively safe and effective treatment for back pain.

    http://nccam.nih.gov/research/results/spotlight/062109.htm


  • 06 Sep 2016 2:04 PM | AAAOM Admin (Administrator)

    07/01/2011 - MENOPAUSE-RELATED SYMPTOMS: TRADITIONAL CHINESE MEDICINE VS HORMONE THERAPY

    Posted By Administration, Friday, July 01, 2011
    Updated: Wednesday, July 16, 2014

    [NIH] OBJECTIVE: To compare the therapeutic effect of Chinese herbal medicine (CHM), acupuncture, and hormone therapy on menopause- related symptoms of peri- and postmenopausal women. 

    STUDY DESIGN: Fifty-seven Chinese women completed 2 months of treatment with either CHM (5 g twice daily, n = 22), acupuncture plus CHM (Kun Bao Wan) 5 g twice daily plus sessions of acupuncture, n = 20), or hormone therapy (n = 15). MAIN OUTCOME MEASURES: Kupperman index score, levels of follicle-stimulating hormone (FSH) and estradiol, and the number of symptoms before and after treatment were the main outcome measures. 

    RESULTS: CHM, acupuncture plus CHM, and hormone therapy significantly decreased Kupperman score (P < .001 in each group) and number of symptoms (P < .05). The mean difference in Kupperman score between baseline and 2 months among the three groups was significantly varied (P = .02). The difference was only between acupuncture plus CHM and CHM with significantly better results by acupuncture plus CHM. Acupuncture plus CHM, as well as hormone therapy, significantly reduced the level of FSH (P < .05), but CHM alone didn't cause any significant decrease in FSH levels (P > .05). The mean difference in the level of FSH between baseline and 2 months among the three groups was significantly different (P = .02). This difference was only between CHM and hormone therapy with significantly better results by hormone therapy. The three treatments didn't make any significant increase in the level of E2 (P > .05). 

    CONCLUSION: application of the combination of Chinese herbal medicine and acupuncture proved as effective as hormone therapy in the treatment of menopause-related symptoms, and it achieved better outcomes than herbal medicine alone.

    http://www.ncbi.nlm.nih.gov/pubmed/22314633#


  • 06 Sep 2016 2:02 PM | AAAOM Admin (Administrator)

    09/01/2011 - NATURAL HERBAL MEDICINE LIANHUAQINGWEN CAPSULE ANTI-INFLUENZA A (H1N1) TRIAL: A RANDOMIZED, DOUBLE BLIND, POSITIVE CONTROLLED CLINICAL TRIAL

    Posted By Administration, Thursday, September 01, 2011
    Updated: Wednesday, July 16, 2014

    Edit Post  Delete Post 

    [NIH] BACKGROUND: The 2009 influenza A (H1N1) virus infection is associated with the high risk of severe complications and is spreading more rapidly throughout the world than other reported seasonal influenzas. This study aimed to evaluate the efficacy and safety of the nature herbal medicine Lianhuaqingwen capsule (LHC) in patients infected with influenza A (H1N1) virus. 

    METHODS: A total of 244 patients aged 16 - 65 years confirmed with influenza A (H1N1) virus infection by the real time RT-PCR were randomized to one of two treatment groups of 122 patients each. Each group assigned to receive either LHC or Oseltamivir for five days and observation for seven days. The patients were enrolled within 36 hours of illness onset if they had an axillary temperature of ≥ 37.4°C and with at least one of the following symptoms: nasal obstruction, runny nose, cough, sore throat, fatigue, headache, myalgia, chills and sweating. The primary end point was the duration of illness. 

    RESULTS: Of 244 patients, 240 (98.36%) patients with a median age 21 years completed the study between October 24, 2009 and November 23, 2009. There were no significant overall differences between LHC treated and Oseltamivir treated patients in the median duration of illness (LHC 69 hours vs. Oseltamivir 85 hours P > 0.05) or the median duration of viral shedding (LHC 103 hours vs. Oseltamivir 96 hours, P > 0.05). However, it was worthwhile to note that LHC significantly reduced the severity of illness and the duration of symptoms including fever, cough, sore throat, and fatigue (P < 0.05). Both study medications were well tolerated. No drug related serious adverse events occurred during the study. 

    CONCLUSIONS: Compared with Oseltamivir, LHC achieved a similar therapeutic effectiveness reduction of the duration of illness and duration of viral shedding. Therefore, LHC might be an alternative therapeutic measure for influenza A (H1N1) virus infections.

    http://www.ncbi.nlm.nih.gov/pubmed/22040504#


  • 06 Sep 2016 2:01 PM | AAAOM Admin (Administrator)

    09/02/2011 - THE EFFICACY AND TOLERABILITY OF FUFANG DANSHEN (SALVIA MILTIORRHIZA) AS ADD-ON ANTIHYPERTENSIVE THERAPY IN TAIWANESE PATIENTS WITH UNCONTROLLED HYPERTENSION

    Posted By Administration, Friday, September 02, 2011
    Updated: Wednesday, July 16, 2014

    [NIH] Hypertension generally requires the use of a combination therapy to achieve the satisfactory control of blood pressure. A traditional Chinese herb, Danshen (Salvia miltiorrhiza), has been shown to have cardioprotective effects in animals and humans. The study investigated the add-on effect of Fufang Danshen extract capsule in Taiwanese hypertensive patients with uncontrolled blood pressure. This was a double-blind, placebo-controlled, randomized, single-center study clinical trial. Fifty-five patients with uncontrolled mild to moderate hypertension were enrolled under current conventional antihypertensive treatment, randomized equally to receive a Fufang Danshen capsule (formula mixture) 1000 mg twice-daily or a placebo capsule for 12 weeks. Primary endpoints were the control rate and the response rate. By ITT analysis at week 12, the control rates were 25.5% in the Fufang Danshen group and 7.3% in the control group (p = 0.016). The response rates were 45.6% in the Fufang Danshen group and 38.2% in the placebo group (p = 0.946). A significant reduction of systolic blood pressure at week 12 was noted in the Fufang Danshen group compared with the placebo group (13.8 vs 4.2 mmHg, p = 0.005). A decrease of pulse rate was also noted in the Fufang Danshen group (- 3.2 vs +2.7/min, p = 0.027). Adverse events were not statistically different between the two groups. It was concluded that Fufang Danshen (Salvia miltiorrhiza) extract reduced systolic blood pressure and pulse rate, and was well tolerated in patients with hypertension.

    http://www.ncbi.nlm.nih.gov/pubmed/21887804#



                                                                      

PO Box 96503 #44114, Washington DC 20090-6503

Reach us at admin@aaaomonline.org

Powered by Wild Apricot Membership Software